RESEARCH NOTICE & LEGAL DISCLAIMER

FOR RESEARCH PURPOSES ONLY. All information provided within the Biolabs Peptides Research Centre is intended strictly for scientific, laboratory, and educational purposes.

Not Medical Advice: The protocols and data presented herein do not constitute medical advice, nursing advice, or a professional healthcare diagnosis.
Non-Therapeutic: These peptides are not intended to diagnose, treat, cure, or prevent any medical condition or disease.
Researcher Responsibility: Any research conducted should be performed by qualified professionals in a controlled laboratory environment. By accessing this data, you acknowledge that you are responsible for following your local laws and institutional safety guidelines.

IPAMORELIN (10mg)

SHOP VIALS

SHOP NOW

SHOP PRE-FILLED PEN

HIGHLIGHTS

Ipamorelin is a synthetic pentapeptide and a highly selective Growth Hormone Secretagogue (GHS). It acts by mimicking ghrelin to stimulate the pituitary gland’s natural production of Growth Hormone (GH). Unlike other secretagogues, Ipamorelin is unique in its specificity—it triggers GH release without significantly increasing ACTH, cortisol, or prolactin levels. This makes it an essential tool for researchers investigating long-term metabolic health, muscle preservation, and cellular repair without the common side effects of hormonal "overflow."

Observed Benefits

Selective GH Amplification: Promotes a clean, pulsatile release of endogenous growth hormone.
Minimal Off-Target Effects: Studied for its ability to avoid spikes in stress hormones (cortisol) and prolactin.
Tissue Regeneration: Supports the repair of bone, muscle, and connective tissue in research models.
Metabolic Support: Observed to enhance fat metabolism and support lean body composition.
Improved Sleep Architecture: Linked to enhanced deep-wave sleep, facilitating physical and cognitive recovery.

Protocol Overview

Research involving Ipamorelin utilizes subcutaneous administration. To maintain measurement precision in our South African laboratory standards, a 10mg vial is reconstituted with 3.0 mL of Bacteriostatic Water. This results in a concentration of approximately 3.33 mg (3333 mcg) per mL. Research is typically conducted daily, ideally in the evening or 30–60 minutes before nocturnal rest, to align with the subject’s natural growth hormone pulses.

Research Protocol Dosing

The following measurements provide the required units on a U-100 insulin syringe to achieve standard research doses.

Initial Research Phase (Weeks 1–2): 100 mcg daily

Dose: 3 units (0.03 mL) on a U-100 syringe.

Intermediate Research Phase (Weeks 3–4): 150 mcg daily

Dose: 5 units (0.05 mL) on a U-100 syringe.

Target Research Phase (Weeks 5–12): 200 mcg to 250 mcg daily

200 mcg Dose: 6 units (0.06 mL) on a U-100 syringe.
250 mcg Dose: 8 units (0.08 mL) on a U-100 syringe.

Frequency Note: Research cycles generally last 8–12 weeks, followed by a 2–4 week break to prevent receptor desensitization. Administration is most effective on an empty stomach (fasted for 2+ hours).

Supplies Needed

Biolabs Peptides Ipamorelin: 10mg Lyophilized Vial.
Reconstitution Liquid: 3.0 mL of Bacteriostatic Water.
Syringes: U-100 Precision Insulin Syringes (0.3 mL or 0.5 mL capacity recommended for these ultra-low volumes).
Prep: Alcohol swabs for vial and research site sterilization.

Storage

Pre-reconstitution (Lyophilized Powder): Store frozen at -20°C (-4°F) for up to 2 years.
Post-reconstitution (Liquid Solution): Must be kept refrigerated at 2–8°C (36–46°F). Standardized at 3.0 mL, the solution is stable for approximately 28–30 days. Protect from light and avoid any vigorous shaking.